Oncotelic Therapeutics (OTLC) Non-Current Assets (2010 - 2026)
Oncotelic Therapeutics (OTLC) recorded Non-Current Assets of $393.29 million in Q2 2026, compared with $26.54 million a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Oncotelic Therapeutics reported Non-Current Assets of $391.89 million.
- Annual Non-Current Assets has a five-year compound annual growth rate of 76.2% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $26.54 million in FY2024 (-10.8%), $29.74 million in FY2023 (-17.0%), $35.81 million in FY2022 (+55.8%) and $22.99 million in FY2021 (-0.3%).
- The Q2 2026 figure is the highest quarterly Non-Current Assets in data going back to Q4 2010.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 73.6% in Q3 2022, against a decline of 25.5% in Q2 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 141.29 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 393.29 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 393.29 Mn |
| Dec 31, 2025 | 391.89 Mn |
| Sep 30, 2025 | 26.54 Mn |
| Jun 30, 2025 | 26.54 Mn |
| Mar 31, 2025 | 26.54 Mn |
| Dec 31, 2024 | 26.54 Mn |
| Sep 30, 2024 | 26.54 Mn |
| Jun 30, 2024 | 29.74 Mn |
| Mar 31, 2024 | 29.74 Mn |
| Dec 31, 2023 | 29.74 Mn |
| Sep 30, 2023 | 29.73 Mn |
| Jun 30, 2023 | 29.73 Mn |
| Mar 31, 2023 | 35.81 Mn |
| Dec 31, 2022 | 35.81 Mn |
| Sep 30, 2022 | 39.92 Mn |
| Jun 30, 2022 | 39.92 Mn |
| Mar 31, 2022 | 22.97 Mn |
| Dec 31, 2021 | 22.99 Mn |
| Sep 30, 2021 | 23.00 Mn |
| Jun 30, 2021 | 23.02 Mn |
API Access
Oncotelic Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();